EZH2 and urinary bladder cancer: As a matter of fact, another group previously demonstrated the H19 activated Wnt/β-catenin pathway by interacting with the RNA binding protein Enhancer of zeste homolog 2 (EZH2), leading to enhanced bladder cancer metastasis24.